Mortality in Two Waves of COVID-19: A Comparative Analysis of a Tertiary Care Hospital in India

Saurabh Vig1, Jitendra K Meena2, Abhishek Kumar3

  • 1Onco-Anesthesiology and Palliative Medicine, National Cancer Institute, All India Institute of Medical Sciences (AIIMS), New Delhi, IND.

Cureus
|October 13, 2023
PubMed

Insights

The second wave of COVID-19 saw a tenfold increase in hospital mortality compared to the first wave in India. This surge was characterized by more severe presentations and deaths directly from COVID-19 acute respiratory distress syndrome.

Area of Science:

  • Infectious Diseases
  • Epidemiology
  • Critical Care Medicine

Background:

  • COVID-19 presented with distinct surges globally.
  • Variations in disease severity and mortality between waves were noted in several countries.

Purpose of the Study:

  • To compare in-hospital mortality between the first and second COVID-19 waves.
  • To analyze differences in disease characteristics and outcomes during these waves at an Indian tertiary care hospital.

Main Methods:

  • Retrospective data collection from a tertiary care hospital in India.
  • Defined wave periods: Wave 1 (March 2020-December 2020), Wave 2 (April 2021-June 2021).
  • Primary outcomes: Total Hospital Mortality Rate (TMR) and Case Fatality Rate (CFR).

Main Results:

  • Wave 2 exhibited approximately a tenfold higher mortality rate than Wave 1 (TMR: 20.3% vs 2.4%; CFR: 17.7% vs 1.5%).
  • Wave 2 cases showed a higher proportion of severe disease at presentation.
  • Faster symptom progression to death and increased deaths from COVID-19 acute respiratory distress syndrome (ARDS) in Wave 2, including in patients without comorbidities.

Conclusions:

  • Findings align with global pooled hospital mortality data.
  • Demonstrated a significant increase in COVID-19 disease severity and mortality during the second wave in the study setting.
  • Highlighted the direct impact of COVID-19 ARDS as a cause of mortality, particularly in Wave 2.

Related Concept Videos

Comparing the Survival Analysis of Two or More Groups01:20

Comparing the Survival Analysis of Two or More Groups

Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
202
Cancer Survival Analysis01:21

Cancer Survival Analysis

Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
359
Actuarial Approach01:20

Actuarial Approach

The actuarial approach, a statistical method originally developed for life insurance risk assessment, is widely used to calculate survival rates in clinical and population studies. This method accounts for participants lost to follow-up or those who die from causes unrelated to the study, ensuring a more accurate representation of survival probabilities.
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
81
Introduction To Survival Analysis01:18

Introduction To Survival Analysis

Survival analysis is a statistical method used to study time-to-event data, where the "event" might represent outcomes like death, disease relapse, system failure, or recovery. A unique feature of survival data is censoring, which occurs when the event of interest has not been observed for some individuals during the study period. This requires specialized techniques to handle incomplete data effectively.
The primary goal of survival analysis is to estimate survival time—the time...
252
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care01:29

Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care

Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
10
Assumptions of Survival Analysis01:15

Assumptions of Survival Analysis

Survival models analyze the time until one or more events occur, such as death in biological organisms or failure in mechanical systems. These models are widely used across fields like medicine, biology, engineering, and public health to study time-to-event phenomena. To ensure accurate results, survival analysis relies on key assumptions and careful study design.
149